Cargando…

DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population

BACKGROUND: Screening for prediabetes and asymptomatic diabetes is important for preventing development to an irreversible stage. The current diagnosis of prediabetes and diabetes is based on blood glucose or HbA1c (an invasive method). The aim of this study was to assess the efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiaopeng, Tang, Jing, Lin, Huandong, Chang, Xinxia, Xia, Mingfeng, Wang, Liu, Yan, Hongmei, Bian, Hua, Gao, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556964/
https://www.ncbi.nlm.nih.gov/pubmed/33054764
http://dx.doi.org/10.1186/s12938-020-00823-x
_version_ 1783594319767142400
author Zhu, Xiaopeng
Tang, Jing
Lin, Huandong
Chang, Xinxia
Xia, Mingfeng
Wang, Liu
Yan, Hongmei
Bian, Hua
Gao, Xin
author_facet Zhu, Xiaopeng
Tang, Jing
Lin, Huandong
Chang, Xinxia
Xia, Mingfeng
Wang, Liu
Yan, Hongmei
Bian, Hua
Gao, Xin
author_sort Zhu, Xiaopeng
collection PubMed
description BACKGROUND: Screening for prediabetes and asymptomatic diabetes is important for preventing development to an irreversible stage. The current diagnosis of prediabetes and diabetes is based on blood glucose or HbA1c (an invasive method). The aim of this study was to assess the efficacy and safety of DS21, a new noninvasive technology, for noninvasive screening for prediabetes and diabetes. METHODS: A total of 939 subjects were divided into a normal control group (NC, n = 308), impaired glucose regulation group (IGR, n = 312), and diabetes (DM) group (n = 319). All subjects underwent the DS21 test, and mean hands–feet, hand, and feet conductance values were analyzed. The diagnostic accuracy of the conductance value was analyzed by receiver-operating characteristic (ROC) curve. RESULTS: The conductance values for hands–feet, hands, and feet in the DM and IGR groups were significantly lower than those in the NC group (all P < 0.01). The area under the ROC curve  (AUCROC) for distinguishing NC/IGR was highest when using hands–feet conductance values (0.766 [95% confidence interval, CI 0.730, 0.803]). However, the AUCROCs of distinguishing NC/abnormal glucose metabolism (AGM, including IGR+DM), non-diabetes (NDM)/DM, and IGR/DM were highest when using conductance values for hands at 0.782 [95% CI 0.752, 0.812], 0.688 [95% CI 0.653, 0.723] and 0.573 [95% CI 0.528, 0.617], respectively (all P < 0.01). Hand conductance of values 75.0 (sensitivity 0.769, specificity 0.660), 77.1 (sensitivity 0.718, specificity 0.695), 68.4 (sensitivity 0.726, specificity 0.555), and 58.1 (sensitivity 0.384, specificity 0.744) were recommended as the screening thresholds for NC/AGM, NC/IGR, NDM/DM, and IGR/DM, respectively. A hand conductance value 66.0 was also recommended to distinguish NC/AGM due to its high sensitivity and high PPV. No adverse events occurred in the test. CONCLUSIONS: DS21 is fast, noninvasive, low cost, reliable and safe, which makes it a feasible device for screening for prediabetes and diabetes, especially in a large population.
format Online
Article
Text
id pubmed-7556964
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75569642020-10-15 DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population Zhu, Xiaopeng Tang, Jing Lin, Huandong Chang, Xinxia Xia, Mingfeng Wang, Liu Yan, Hongmei Bian, Hua Gao, Xin Biomed Eng Online Research BACKGROUND: Screening for prediabetes and asymptomatic diabetes is important for preventing development to an irreversible stage. The current diagnosis of prediabetes and diabetes is based on blood glucose or HbA1c (an invasive method). The aim of this study was to assess the efficacy and safety of DS21, a new noninvasive technology, for noninvasive screening for prediabetes and diabetes. METHODS: A total of 939 subjects were divided into a normal control group (NC, n = 308), impaired glucose regulation group (IGR, n = 312), and diabetes (DM) group (n = 319). All subjects underwent the DS21 test, and mean hands–feet, hand, and feet conductance values were analyzed. The diagnostic accuracy of the conductance value was analyzed by receiver-operating characteristic (ROC) curve. RESULTS: The conductance values for hands–feet, hands, and feet in the DM and IGR groups were significantly lower than those in the NC group (all P < 0.01). The area under the ROC curve  (AUCROC) for distinguishing NC/IGR was highest when using hands–feet conductance values (0.766 [95% confidence interval, CI 0.730, 0.803]). However, the AUCROCs of distinguishing NC/abnormal glucose metabolism (AGM, including IGR+DM), non-diabetes (NDM)/DM, and IGR/DM were highest when using conductance values for hands at 0.782 [95% CI 0.752, 0.812], 0.688 [95% CI 0.653, 0.723] and 0.573 [95% CI 0.528, 0.617], respectively (all P < 0.01). Hand conductance of values 75.0 (sensitivity 0.769, specificity 0.660), 77.1 (sensitivity 0.718, specificity 0.695), 68.4 (sensitivity 0.726, specificity 0.555), and 58.1 (sensitivity 0.384, specificity 0.744) were recommended as the screening thresholds for NC/AGM, NC/IGR, NDM/DM, and IGR/DM, respectively. A hand conductance value 66.0 was also recommended to distinguish NC/AGM due to its high sensitivity and high PPV. No adverse events occurred in the test. CONCLUSIONS: DS21 is fast, noninvasive, low cost, reliable and safe, which makes it a feasible device for screening for prediabetes and diabetes, especially in a large population. BioMed Central 2020-10-14 /pmc/articles/PMC7556964/ /pubmed/33054764 http://dx.doi.org/10.1186/s12938-020-00823-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhu, Xiaopeng
Tang, Jing
Lin, Huandong
Chang, Xinxia
Xia, Mingfeng
Wang, Liu
Yan, Hongmei
Bian, Hua
Gao, Xin
DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population
title DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population
title_full DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population
title_fullStr DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population
title_full_unstemmed DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population
title_short DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population
title_sort ds21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in chinese population
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556964/
https://www.ncbi.nlm.nih.gov/pubmed/33054764
http://dx.doi.org/10.1186/s12938-020-00823-x
work_keys_str_mv AT zhuxiaopeng ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation
AT tangjing ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation
AT linhuandong ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation
AT changxinxia ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation
AT xiamingfeng ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation
AT wangliu ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation
AT yanhongmei ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation
AT bianhua ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation
AT gaoxin ds21anewnoninvasivetechnologyiseffectiveandsafeforscreeningforprediabetesanddiabetesinchinesepopulation